leisure time -WSS

leisure time

author：knowledge 2025-09-27 10:05:23 - browse：26

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Ibogaine psychedelic therapy for opioid addiction unlikely, official says

focus

WSS

New chief aims to remake Sanofi Genzyme

Why the advice to take all your antibiotics may be wrong

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Why Marc Tessier

A new deal aims to ramp up use of AI in rehab care decisions

Biden White House, tech companies launch new safeguards around emerging AI technology

focus

leisure time

Sign up for Morning Rounds

knowledge

Heart attack and stroke risk calculators need revising

CRISPR technology availability, affordability needs to be expanded

Continuity nursing helped my family in our darkest PICU moments

Asbestos ban is immediate, but health effects will linger for decades

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New chief aims to remake Sanofi Genzyme

After affirmative action ruling, medical educators look to 'holistic review'

CRISPR technology availability, affordability needs to be expanded

Heart attack and stroke risk calculators need revising

Asbestos ban is immediate, but health effects will linger for decades

knowledge

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Listen: BridgeBio's big week & Lilly's Alzheimer's data

EMA weighs against approval for Mirati's lung cancer drug

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Hey, doctors: Don't be no

A new deal aims to ramp up use of AI in rehab care decisions

focus

focus

focus

Wikipedia